UPDATE: BMO Capital Upgrades ARIAD (ARIA) to Outperform; Assets Likely to Attract M&A Interest
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/16/2024
- Wall Street stocks close lower on higher Treasury yields, rate expectations
- Powell says recent inflation data point to need to keep rates higher for longer
- United Airlines maintains forecast after Q1 results top Wall Street estimates
- UnitedHealth (UNH) beats earnings, revenue estimates in Q1; shares up
- Bank of America profit hurt by losses on credit cards, office loans
- Trump Media & Technology Group (DJT) Files S-1
- Tesla (TSLA) Senior VP Drew Baglino Is Said To Leave The Company - Bloomberg
- GE HealthCare (GEHC) Announces Resignation of Jan Makela, CEO of Imaging
- General Motors (GM) Said to be Moving Detroit HQ to Dan Gilbert's Hudson Tower - Bloomberg
- Biohaven Pharma (BHVN) presents update on degrader platform and summary of progress to date in Phase 1 single ascending dose study for BHV-1300
- After-hours movers: United Airlines, J.B. Hunt, and more
- Midday movers: Morgan Stanley, UnitedHealth rise; Tesla falls
- Morgan Stanley, UnitedHealth and Bank of America rise premarket; Tesla falls
- After-hours movers: Tesla, Gildan Activewear, Macatawa Bank, and more
- Midday movers: Goldman Sachs and Meta Platforms rise; Apple and Tesla fall
Ariad Pharmaceuticals (ARIA) Sees Upside Action
January 24, 2014 9:38 AM ESTAriad Pharmaceuticals, Inc. (NASDAQ: ARIA) seeing upside early. Shares up 3%... More
Ariad Pharmaceuticals (ARIA) Pops On Takeover Speculation
January 23, 2014 9:27 AM ESTAriad Pharmaceuticals, Inc. (NASDAQ: ARIA) is up 8% in early trade on speculation the company has been approached about a possible takeover. Reports come from the Daily Mail so should be taken with a grain of salt.... More
